Literature DB >> 11939729

The morphologic spectrum of metastatic prostatic adenocarcinoma to the lung: special emphasis on histologic features overlapping with other pulmonary neoplasms.

John N Copeland1, Mahul B Amin, Peter A Humphrey, Pheroze Tamboli, Jae Y Ro, Anthony A Gal.   

Abstract

We undertook a detailed histologic study to identify specific morphologic features that may aid in distinguishing prostatic adenocarcinoma with lung metastases (PALM) from other pulmonary tumors with similar histologic features. In 16 cases, we found 3 predominant architectural patterns: microacinar (n = 10), tubulopapillary (ductal; n = 4), and carcinoid-like (n = 2). Characteristic features of PALM included small acinar and/or cribriform growth, frequent lymphangitic permeation, lack of stromal response, uniform round nuclei with prominent nucleoli, intraluminal blue mucin, and prominent cell borders. By immunohistochemical staining, prostate-specific antigen and prostate-specific acid phosphatase were present in 13 of 14 and 13 of 13 cases, respectively. Metastatic prostatic duct adenocarcinoma exhibited morphologic features similar to metastatic colonic adenocarcinoma. Two cases had a carcinoid-like appearance with nested or solid architecture, parachromatin clearing, and prominent nucleoli, but lacked the finely stippled chromatin pattern of carcinoid tumors. Several features that may result in misinterpretation or lack of association of the neoplasm in the lung with a prostatic primary include lung metastasis preceding the detection of a prostatic primary tumor, solitary pulmonary nodule, tubulopapillary (ductal) or carcinoid-like pattern, scant material in which histologic features of metastatic prostate carcinoma are not fully appreciated, and frequent necrosis. Attention to specific discriminating histologic features, supported by immunohistochemical staining, may be useful in the differential diagnosis, which is therapeutically and prognostically critical.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11939729     DOI: 10.1309/PCND-T3N0-5K01-D454

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  11 in total

Review 1.  The update of prostatic ductal adenocarcinoma.

Authors:  Tantan Liu; Yingmei Wang; Ru Zhou; Haiyang Li; Hong Cheng; Jing Zhang
Journal:  Chin J Cancer Res       Date:  2016-02       Impact factor: 5.087

2.  Metastatic ductal carcinoma of the prostate: a rare variant responding to a common treatment.

Authors:  Aalok Kumar; Som Dave Mukherjee
Journal:  Can Urol Assoc J       Date:  2010-04       Impact factor: 1.862

3.  Ductal adenocarcinoma of the prostate: increased mortality risk and decreased serum prostate specific antigen.

Authors:  Todd M Morgan; Christopher J Welty; Funda Vakar-Lopez; Daniel W Lin; Jonathan L Wright
Journal:  J Urol       Date:  2010-10-16       Impact factor: 7.450

Review 4.  Ductal adenocarcinoma of the prostate: A systematic review and meta-analysis of incidence, presentation, prognosis, and management.

Authors:  Nithesh Ranasinha; Altan Omer; Yiannis Philippou; Eli Harriss; Lucy Davies; Ken Chow; Paolo M Chetta; Andrew Erickson; Timothy Rajakumar; Ian G Mills; Richard J Bryant; Freddie C Hamdy; Declan G Murphy; Massimo Loda; Christopher M Hovens; Niall M Corcoran; Clare Verrill; Alastair D Lamb
Journal:  BJUI Compass       Date:  2021-01-05

5.  Immunohistochemical profile of ductal adenocarcinoma of the prostate.

Authors:  Amanda H Seipel; Hemamali Samaratunga; Brett Delahunt; Fredrik Wiklund; Peter Wiklund; Johan Lindberg; Henrik Grönberg; Lars Egevad
Journal:  Virchows Arch       Date:  2014-07-25       Impact factor: 4.064

6.  Mysterious Left Atrial Mass in a Patient With Metastatic Prostate Cancer.

Authors:  Rafsan Ahmed; Seyed Zaidi; Michelle Feinberg; Suzette Graham-Hill
Journal:  Cureus       Date:  2022-03-16

7.  Diverse Immunoprofile of Ductal Adenocarcinoma of the Prostate with an Emphasis on the Prognostic Factors.

Authors:  Se Un Jeong; Anuja Kashikar Kekatpure; Ja-Min Park; Minkyu Han; Hee Sang Hwang; Hui Jeong Jeong; Heounjeong Go; Yong Mee Cho
Journal:  J Pathol Transl Med       Date:  2017-08-09

Review 8.  [Progress in Research on the Cribriform Component in Lung Adenocarcinoma].

Authors:  Qifeng Ding; Donglai Chen; Wei Wang; Yongbing Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2020-05-26

9.  Perineal recurrence of prostate ductal adenocarcinoma after transperineal brachytherapy: a case report and literature review.

Authors:  Takashi Fukagai; Kidai Hirayama; Masashi Morita; Kota Nishimura; Jin Yamatoya; Tetsuo Noguchi; Yu Ogawa; Atsushi Igarashi; Madoka Morota; Masako Kato; Kazuhiko Oshinomi; Yoshio Ogawa; Toyonori Tsuzuki
Journal:  J Contemp Brachytherapy       Date:  2020-12-16

10.  HoxB13 expression in ductal type adenocarcinoma of prostate: clinicopathologic characteristics and its utility as potential diagnostic marker.

Authors:  Cheol Keun Park; Su-Jin Shin; Yoon Ah Cho; Jin Woo Joo; Nam Hoon Cho
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.